Tech Company Financing Transactions
Nomic Funding Round
Nomic, based in Somerville, secured $17 million from Lux Capital, Casdin Capital and SR One Capital Management.
Transaction Overview
Company Name
Announced On
12/10/2021
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series A
Investors
Proceeds Purpose
Nomic will deploy the new capital to grow the teams in Montreal and Boston, expand access to the platform by increasing profiling capacity to 100,000 samples a quarter by Q2 2022, scale the nELISA to 500 on-boarded proteins, as well as begin the development of various new modalities such as the identification of post-translational modification.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15 Ward St.
Somerville, MA 02143
USA
Somerville, MA 02143
USA
Phone
Undisclosed
Website
Email Address
Overview
Despite decades of research and funding, proteomics remains the 'next frontier' in biology and medicine. More than ever, scientists need a broadly applicable, high-throughput, and cost-efficient proteomics technology that can be implemented from discovery to the clinic.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Milad Dagher
Browse more venture capital transactions:
Prev: 12/10/2021: Cerebral venture capital transaction
Next: 12/10/2021: Atom Learning venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs